Actively Recruiting
Effect of Head Acupuncture on Residual Symptoms After Canalith Repositioning Procedure for Benign Paroxysmal Positional Vertigo: a Single-center Randomized Controlled Trial
Led by Xi'an No.3 Hospital · Updated on 2023-12-15
120
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder often treated with manual repositioning techniques. Despite successful repositioning, many patients experience lingering symptoms such as dizziness, instability, and emotional effects that impact daily life. This research aims to explore risk factors, gait characteristics, and compare the effectiveness of electroacupuncture and betahistine for treating these residual symptoms in BPPV patients. Participants diagnosed with BPPV will undergo specific repositioning maneuvers based on the affected canal. Those with residual symptoms after repositioning will be randomly assigned to two groups: one receiving electroacupuncture daily for five days targeting the vertigo-auditory area, and the other receiving oral betahistine three times daily for four weeks. The study runs from November 2023 to November 2026 and includes follow-up assessments. During the study, participants will be evaluated at baseline and multiple points after treatment using dizziness scales, balance tests, gait assessments, and questionnaires. Data on symptoms and function will be collected up to four weeks post-treatment. Safety and treatment adherence will be monitored, with outcome measures including the Visual Analog Scale and Dizziness Handicap Inventory scores one week after treatment to determine treatment effects.
CONDITIONS
Brief Title
Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years
- Confirmed diagnosis of benign paroxysmal positional vertigo (BPPV) with successful repositioning maneuver
- Presence of residual symptoms such as dizziness, heaviness in the head, unsteady gait after repositioning
- No communication barriers or visual impairments
- Patient and family agree to the treatment plan
You will not qualify if you...
- Presence of other ear diseases or history of head trauma or surgery
- Patients who are weak or unable to tolerate treatment
- Pregnant women
- Prior vestibular rehabilitation training before this treatment
- Joint diseases affecting balance and walking
- History of brain organic diseases such as tumors, stroke, or cerebral hemorrhage
- Severe neurological diseases
- Incomplete data or patients who withdraw from treatment midway
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - Up to 2 days after repositioning maneuver
Participants are screened for eligibility to participate in the trial.
1 visit for reassessment to confirm successful repositioning and eligibility
Duration - 4 weeks
Participants receive treatment for residual symptoms after successful repositioning of BPPV using either electroacupuncture or oral betahistine.
Daily visits for 5 days for electroacupuncture or oral medication taken three times daily for 4 weeks with follow-up assessments
Duration - Up to 4 weeks after treatment start
Participants are monitored for treatment outcomes including symptom assessments and balance function tests.
Visits at 3 days, 1 week, 2 weeks, and 4 weeks after treatment start
Trial Site Locations
Total: 1 location
1
Xi'an No3 Hospital
Xi'an, China
Actively Recruiting
Research Team
M
Mingze Chang, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here